TOP  >  Research  >  HPC- and AI-driven Drug Development Platform Division

Yasushi Okuno
Director
HPC- and AI-driven Drug Development Platform Division

Life science in the future cannot be fully advanced by practicing data science, simulation science, and experimental science independent of each other. Deep integration of these fields is essential in order to discover unexplored biological phenomena. This Division aims to develop novel methodologies to integrate AI, molecular simulation, and experimental sciences and establish an integrated platform for HPC- and AI-driven drug development. In doing so, we will explore the frontier of life science, drug development, and healthcare.

Research Areas
  • Creation of new life science by integrating simulation, AI, and experimental sciences
  • Development of novel types of drugs and treatments (from small molecules to large molecules; from basic to clinical applications)
  • Establishment of an integrated platform for HPC- and AI-driven life science
  • Practical application of drug development, healthcare, and life science

HPC- and AI-driven Drug Development Platform Division Units